Skip to main content

Nasdaq Technology

Is Now the Right Time to Embrace Biotech ETFs?

3 years 3 months ago
Following an initial rise in revenues due to the high demand for COVID-19 vaccinations and antiviral therapies during the pandemic, the biotech industry saw revenue stabilization in 2022. Revenues at public biotech companies fell
Checked
8 minutes 58 seconds ago
This feed is responsible for generating the rss feed related to the topic Technology
Subscribe to Nasdaq Technology feed